Abstract
Bee venom (BV) from honey bee (Apis Melifera L.) contains at least 18 pharmacologically active components including melittin (MLT), phospholipase A2 (PLA2), and apamin etc. BV is safe for human treatments dose dependently and proven to possess different healing properties including antibacterial and antiparasitidal properties. Nevertheless, antiviral properties of BV have not well investigated. Hence, we identified the potential antiviral properties of BV and its component against a broad panel of viruses. Co-incubation of non-cytotoxic amounts of BV and MLT, the main component of BV, significantly inhibited the replication of enveloped viruses such as Influenza A virus (PR8), Vesicular Stomatitis Virus (VSV), Respiratory Syncytial Virus (RSV), and Herpes Simplex Virus (HSV). Additionally, BV and MLT also inhibited the replication of non-enveloped viruses such as Enterovirus-71 (EV-71) and Coxsackie Virus (H3). Such antiviral properties were mainly explained by virucidal mechanism. Moreover, MLT protected mice which were challenged with lethal doses of pathogenic influenza A H1N1 viruses. Therefore, these results provides the evidence that BV and MLT could be a potential source as a promising antiviral agent, especially to develop as a broad spectrum antiviral agent.
References
Arts, I.C. and Hollman, P.C. 2005. Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 81, 317S–325S.
Baghian, A., Jaynes, J., Enright, F., and Kousoulas, K.G. 1997. An amphipathic alpha-helical synthetic peptide analogue of melittin inhibits herpes simplex virus-1 (HSV-1)-induced cell fusion and virus spread. Peptides 18, 177–183.
Baghian, A. and Kousoulas, K.G. 1993. Role of the Na+, K+ pump in herpes simplex type 1-induced cell fusion: melittin causes specific reversion of syncytial mutants with the syn1 mutation to Syn+ (wild-type) phenotype. Virology 196, 548–556.
Billingham, M.E., Morley, J., Hanson, J.M., Shipolini, R.A., and Vernon, C.A. 1973. Letter: an anti-inflammatory peptide from bee venom. Nature 245, 163–164.
Bouvier, N.M. and Lowen, A.C. 2010. Animal models for influenza virus pathogenesis and transmission. Viruses 2, 1530–1563.
Cinatl, J., Morgenstern, B., Bauer, G., Chandra, P., Rabenau, H., and Doerr, H.W. 2003. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 361, 2045–2046.
Clague, M.J. and Cherry, R.J. 1988. Comparison of p25 presequence peptide and melittin. Red blood cell haemolysis and band 3 aggregation. Biochem. J. 252, 791–794.
Coil, D.A. and Miller, A.D. 2004. Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus. J. Virol. 78, 10920–10926.
Cuppoletti, J. and Abbott, A.J. 1990. Interaction of melittin with the (Na+ + K+)ATPase: evidence for a melittin-induced conformational change. Arch. Biochem. Biophys. 283, 249–257.
DeGrado, W.F., Musso, G.F., Lieber, M., Kaiser, E.T., and Kezdy, F.J. 1982. Kinetics and mechanism of hemolysis induced by melittin and by a synthetic melittin analogue. Biophys. J. 37, 329–338.
Dempsey, C.E. 1990. The actions of melittin on membranes. Biochim. Biophys. Acta 1031, 143–161.
Dufourcq, J., Faucon, J.F., Fourche, G., Dasseux, J.L., Le Maire, M., and Gulik-Krzywicki, T. 1986a. Morphological changes of phosphatidylcholine bilayers induced by melittin: vesicularization, fusion, discoidal particles. Biochim. Biophys. Acta 859, 33–48.
Dufourc, E.J., Smith, I.C., and Dufourcq, J. 1986b. Molecular details of melittin-induced lysis of phospholipid membranes as revealed by deuterium and phosphorus NMR. Biochemistry 25, 6448–6455.
Esser, A.F., Bartholomew, R.M., Jensen, F.C., and Muller-Eberhard, H.J. 1979. Disassembly of viral membranes by complement independent of channel formation. Proc. Natl. Acad. Sci. USA 76, 5843–5847.
Gastaminza, P., Kapadia, S.B., and Chisari, F.V. 2006. Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles. J. Virol. 80, 11074–11081.
Habermann, E. 1972. Bee and wasp venoms. Science 177, 314–322.
Hwang, D.S., Kim, S.K., and Bae, H. 2015. Therapeutic effects of bee venom on immunological and neurological diseases. Toxins 7, 2413–2421.
Ji, H.F., Li, X.J., and Zhang, H.Y. 2009. Natural products and drug discovery. Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia? EMBO Rep. 10, 194–200.
Kim, J.H., Weeratunga, P., Kim, M.S., Nikapitiya, C., Lee, B.H., Uddin, M.B., Kim, T.H., Yoon, J.E., Park, C., Ma, J.Y., et al. 2016. Inhibitory effects of an aqueous extract from Cortex Phellodendri on the growth and replication of broad-spectrum of viruses in vitro and in vivo. BMC Complement. Altern. Med. 16, 265.
Kuchinka, E. and Seelig, J. 1989. Interaction of melittin with phosphatidylcholine membranes. Binding isotherm and lipid headgroup conformation. Biochemistry 28, 4216–4221.
Lariviere, W.R. and Melzack, R. 1996. The bee venom test: a new tonic-pain test. Pain 66, 271–277.
Li, Q., Zhao, Z., Zhou, D., Chen, Y., Hong, W., Cao, L., Yang, J., Zhang, Y., Shi, W., Cao, Z., et al. 2011. Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARSCoV and influenza H5N1 viruses. Peptides 32, 1518–1525.
Lorin, C., Combredet, C., Labrousse, V., Mollet, L., Desprès, P., and Tangy, F. 2005. A paediatric vaccination vector based on live attenuated measles vaccine. Therapie 60, 227–233.
Mahaney, J.E. and Thomas, D.D. 1991. Effects of melittin on molecular dynamics and Ca-ATPase activity in sarcoplasmic reticulum membranes: electron paramagnetic resonance. Biochemistry 30, 7171–7180.
Maher, S. and McClean, S. 2006. Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro. Biochem. Pharmacol. 71, 1289–1298.
Marcos, J.F., Beachy, R.N., Houghten, R.A., Blondelle, S.E., and Pérez-Payá, E. 1995. Inhibition of a plant virus infection by analogs of melittin. Proc. Natl. Acad. Sci. USA 92, 12466–12469.
Matanic, V.C. and Castilla, V. 2004. Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus. Int. J. Antimicrob. Agents 23, 382–389.
Park, H.J., Lee, S.H., Son, D.J., Oh, K.W., Kim, K.H., Song, H.S., Kim, G.J., Oh, G.T., Yoon, D.Y., and Hong, J.T. 2004. Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit. Arthritis Rheum. 50, 3504–3515.
Reed, L.J. and Muench, H. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27, 493–497.
Scagnolari, C., Vicenzi, E., Bellomi, F., Stillitano, M.G., Pinna, D., Poli, G., Clementi, M., Dianzani, F., and Antonelli, G. 2004. Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons. Antivir. Ther. 9, 1003–1011.
Seal, B.S., King, D.J., and Bennett, J.D. 1995. Characterization of Newcastle disease virus isolates by reverse transcription PCR coupled to direct nucleotide sequencing and development of sequence database for pathotype prediction and molecular epidemiological analysis. J. Clin. Microbiol. 33, 2624–2630.
Son, D.J., Lee, J.W., Lee, Y.H., Song, H.S., Lee, C.K., and Hong, J.T. 2007. Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol. Ther. 115, 246–270.
Strober, W. 2001. Trypan blue exclusion test of cell viability. Curr. Protoc. Immunol. Appendix 3, Appendix 3B.
Terwilliger, T.C., Weissman, L., and Eisenberg, D. 1982. The structure of melittin in the form I crystals and its implication for melittin’s lytic and surface activities. Biophys. J. 37, 353–361.
Tosteson, M.T., Holmes, S.J., Razin, M., and Tosteson, D.C. 1985. Melittin lysis of red cells. J. Membr. Biol. 87, 35–44.
Triggiani, M., Granata, F., Frattini, A., and Marone, G. 2006. Activation of human inflammatory cells by secreted phospholipases A2. Biochim. Biophys. Acta. 1761, 1289–1300.
Wachinger, M., Kleinschmidt, A., Winder, D., von Pechmann, N., Ludvigsen, A., Neumann, M., Holle, R., Salmons, B., Erfle, V., and Brack-Werner, R. 1998. Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. J. Gen. Virol. 79 (Pt 4), 731–740.
Wachinger, M., Saermark, T., and Erfle, V. 1992. Influence of amphipathic peptides on the HIV-1 production in persistently infected T lymphoma cells. FEBS Lett. 309, 235–241.
Weeratunga, P., Uddin, M.B., Kim, M.S., Lee, B.H., Kim, T.H., Yoon, J.E., Ma, J.Y., Kim, H., and Lee, J.S. 2016. Interferon-mediated antiviral activities of Angelica tenuissima Nakai and its active components. J. Microbiol. 54, 57–70.
Wen, Y.Y., Chang, T.Y., Chen, S.T., Li, C., and Liu, H.S. 2003. Comparative study of enterovirus 71 infection of human cell lines. J. Med. Virol. 70, 109–118.
Author information
Authors and Affiliations
Corresponding authors
Additional information
These authors contributed equally to this work.
An erratum to this article is available at http://dx.doi.org/10.1007/s12275-017-0668-y.
Rights and permissions
About this article
Cite this article
Uddin, M.B., Lee, BH., Nikapitiya, C. et al. Inhibitory effects of bee venom and its components against viruses in vitro and in vivo . J Microbiol. 54, 853–866 (2016). https://doi.org/10.1007/s12275-016-6376-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-016-6376-1
Keywords
- anti-viral activity
- bee venom
- melittin
- virucidal effect